Idiopathic Hypercalcemia in Decompensated Cirrhosis: Reexploring an Entity in Oblivion.

Autor: Ragate DC; Department of Internal Medicine, Postgraduate Institute of Medical Education & Research, Chandigarh, India., Taneja S; Department of Hepatology, Postgraduate Institute of Medical Education & Research, Chandigarh, India., Roy A; Department of Hepatology, Postgraduate Institute of Medical Education & Research, Chandigarh, India., Duseja AK; Department of Hepatology, Postgraduate Institute of Medical Education & Research, Chandigarh, India., Dhiman RK; Department of Hepatology, Postgraduate Institute of Medical Education & Research, Chandigarh, India., Singh V; Department of Hepatology, Postgraduate Institute of Medical Education & Research, Chandigarh, India.
Jazyk: angličtina
Zdroj: Journal of clinical and experimental hepatology [J Clin Exp Hepatol] 2021 Mar-Apr; Vol. 11 (2), pp. 270-272. Date of Electronic Publication: 2020 May 11.
DOI: 10.1016/j.jceh.2020.05.004
Abstrakt: Hypercalcemia is a rare metabolic abnormality seen in patients with cirrhosis and is usually considered a paraneoplastic manifestation of hepatocellular carcinoma. Idiopathic hypercalcemia in cirrhosis is a diagnosis of exclusion, which is considered when all the causes of hypercalcemia have been ruled out. Here, we report a rare case of idiopathic hypercalcemia presenting as acute kidney injury in a case of decompensated cirrhosis, managed with adequate hydration and injection of ibandronate and intranasal calcitonin, leading to the normalization of serum calcium and resolution of acute kidney injury.
(© 2020 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: